Gene on Link LLC, the US-based laboratory of Kim Forest (金萬林), signed a strategic agreement on the 20th with the Incinta Reproductive Fertility Center (RFC) in California to provide PGT-A (Preimplantation Genetic Testing for Aneuploidies) and precision reproductive genomic services.

Market Drivers & Technical Synergy:

• Policy Tailwinds: California’s Senate Bill SB-729 (effective Jan 1, 2026) mandates that large insurance providers cover infertility diagnosis and treatment, including IVF. This is expected to increase IVF volume by 15–20% and reduce out-of-pocket costs by 30–50%.
• Clinical Efficacy: PGT-A is recognized for increasing IVF success rates to 60–70% and reducing miscarriage rates from ~25% to under 10%, a critical factor for the 60% of seekers aged 35+ who face high embryonic abnormality rates.
• Global Hub: RFC, led by Dr. James Lin, manages over 8,000 cases annually and attracts significant volume from Chinese-speaking families in Taiwan, Hong Kong, and Southeast Asia, navigating the regulatory limitations on surrogacy and single-parent fertility in those regions.

Resource: 金萬林美國實驗室 Gene on Link 攜手加州生殖中心 推動精準生殖檢測